Terms: = Germ cell tumor AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Treatment
292 results:
1. A Prognostic Methylation-Driven Two-Gene Signature in Medulloblastoma.
Michaelsen GL; da Silva LDRE; de Lima DS; Jaeger MDC; Brunetto AT; Dalmolin RJS; Sinigaglia M
J Mol Neurosci; 2024 Apr; 74(2):47. PubMed ID: 38662144
[TBL] [Abstract] [Full Text] [Related]
2. Genistin Represses the Proliferation and Angiogenesis While Accelerating the Apoptosis of Glioma cells by Modulating the FOXC1-Mediated Wnt Signaling Pathway.
Lan X; Gui Z; Chen T; Tang M; Wang H
Discov Med; 2024 Feb; 36(181):332-342. PubMed ID: 38409838
[TBL] [Abstract] [Full Text] [Related]
3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
4. TUBA1A licenses apc/C-mediated mitotic progression to drive glioblastoma growth by inhibiting PLK3.
Wen J; Wang Q; Zhang W; Wang W
FEBS Lett; 2023 Dec; 597(24):3072-3086. PubMed ID: 37873730
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Differences Between Surveillance and Active treatment After Initial Orchiectomy in Patients With Stage I Mixed germ cell tumors of the Testis: A Propensity Score Matching Analysis.
Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
[TBL] [Abstract] [Full Text] [Related]
6. Modulating Wnt/β-Catenin Signaling Pathway on U251 and T98G Glioblastoma cell Lines Using a Combination of Paclitaxel and Temozolomide, A Molecular Docking Simulations and Gene Expression Study.
Jamalpour S; Alinezhad A; Sabah JT; Vazifehmand R; Behrooz AB; Hamzah ASA; Davazdahemami AA; Homaie FM; Maddah SM
Chem Pharm Bull (Tokyo); 2023; 71(10):766-774. PubMed ID: 37779078
[TBL] [Abstract] [Full Text] [Related]
7. Cost-utility analysis of Pembrolizumab compared to other alternative immunotherapy and chemotherapy treatments for patients with advanced melanoma in Iran.
Bashari N; Safaei Lari M; Darvishi A; Daroudi R
Expert Rev Pharmacoecon Outcomes Res; 2024 Feb; 24(2):273-284. PubMed ID: 37750606
[TBL] [Abstract] [Full Text] [Related]
8. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
[TBL] [Abstract] [Full Text] [Related]
9. Gastric schwannoma: A retrospective analysis of clinical characteristics, treatments, and outcomes.
Li J; Chen JH; Huang WF; Liu M; Hong SK; Zhang JY
Asian J Surg; 2024 Jan; 47(1):407-412. PubMed ID: 37741754
[TBL] [Abstract] [Full Text] [Related]
10. Laparoscopic resection for gastric schwannoma larger than 30 mm with long-term outcomes.
Jiang X; Zhao M; Wu J; Ding Y; Wang J
BMC Surg; 2023 Sep; 23(1):284. PubMed ID: 37726737
[TBL] [Abstract] [Full Text] [Related]
11. Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.
Mantica M; Drappatz J; Lieberman F; Hadjipanayis CG; Lunsford LD; Niranjan A
J Neurooncol; 2023 Aug; 164(1):179-190. PubMed ID: 37515669
[TBL] [Abstract] [Full Text] [Related]
12. Molecular typing and mutational characterization of rectal neuroendocrine neoplasms.
Duan X; Zhao M; Yin X; Mi L; Shi J; Li N; Han X; Han G; Wang J; Hou J; Yin F
Cancer Med; 2023 Aug; 12(15):16207-16220. PubMed ID: 37387515
[TBL] [Abstract] [Full Text] [Related]
13. Current Patterns of treatment and Outcomes in Advanced Melanoma at a Single Institution.
Rose MA; Miura J; Sharon C; Ermer JP; Karakousis G; Wachtel H
J Surg Res; 2023 Nov; 291():25-33. PubMed ID: 37331189
[TBL] [Abstract] [Full Text] [Related]
14. Predictors of Progression-Free Survival in Patients With Spinal Intramedullary Ependymoma: A Multicenter Retrospective Study by the Neurospinal Society of Japan.
Naito K; Umebayashi D; Kurokawa R; Endo T; Mizuno M; Hoshimaru M; Kim P; Hida K; Takami T;
Neurosurgery; 2023 Nov; 93(5):1046-1056. PubMed ID: 37255289
[TBL] [Abstract] [Full Text] [Related]
15. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract] [Full Text] [Related]
16. Impact of extent of resection and adjuvant therapy in diffuse gliomas of the spine.
Chalif EJ; Foster C; Sack K; Patrick H; Mozaffari K; Rosner M
Spine J; 2023 Jul; 23(7):1015-1027. PubMed ID: 36804437
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
[TBL] [Abstract] [Full Text] [Related]
18. Tracheobronchial schwannoma: a case report and literature review.
Lina G; Pengguo H; Zhihua X; Jianxin W; Baoqin B; Mingyue Z; Junping S
J Int Med Res; 2023 Jan; 51(1):3000605221149891. PubMed ID: 36708207
[TBL] [Abstract] [Full Text] [Related]
19. Awake craniotomy for operative treatment of brain gliomas - experience from University Medical Centre Ljubljana.
Zele T; Velnar T; Koritnik B; Bosnjak R; Markovic-Bozic J
Radiol Oncol; 2023 Jun; 57(2):191-200. PubMed ID: 36653903
[TBL] [Abstract] [Full Text] [Related]
20. MN1 altered astroblastoma with apc and LRP1B gene mutations: a unique variant in the cervical spine of a pediatric patient.
Mugge L; Dang DD; Stabingas K; Keating G; Rossi C; Keating R
Childs Nerv Syst; 2023 May; 39(5):1309-1315. PubMed ID: 36648513
[TBL] [Abstract] [Full Text] [Related]
[Next]
